Ibezapolstat is a small molecule commercialized by Acurx Pharmaceuticals, with a leading Phase II program in Clostridioides difficile Infections (Clostridium difficile Associated Disease).

Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...